Immune characterization of a Colombian family cluster with SARS-CoV-2 infection

Introduction: Immunological markers have been described during COVID-19 and persist after recovery. These immune markers are associated with clinical features among SARSCoV- 2 infected individuals. Nevertheless, studies reporting a comprehensive analysis of the immune changes occurring during SARS-C...

Full description

Autores:
Aguilar Jiménez, Wbeimar
Flórez Álvarez, Lizdany
Rincón, Daniel S.
Marín Palma, Damariz
Sanchez Martinez, Alexandra
Martínez Moreno, Jahnnyer
Zapata Cardona, María Isabel
Loaiza Durán, John Darío
Cardenas, Constanza
Guzman, Fanny
Velilla Hernandez, Paula Andrea
Taborda, Natalia Andrea
Zapata Builes, Wildeman
Hernández López, Juan Carlos
Diaz, Francisco Javier
Rugeles López, María Teresa
Tipo de recurso:
Article of investigation
Fecha de publicación:
2021
Institución:
Universidad Cooperativa de Colombia
Repositorio:
Repositorio UCC
Idioma:
OAI Identifier:
oai:repository.ucc.edu.co:20.500.12494/43606
Acceso en línea:
https://hdl.handle.net/20.500.12494/43606
Palabra clave:
Coronavirus infections
Inflammation
Killer cells, natural
T-lymphocytes
Antibodies
Neutralizing
Coronavirus infections
Inflammation
Killer cells, natural
T-lymphocytes
Antibodies
Neutralizing
Rights
openAccess
License
Atribución
id COOPER2_dbfdffffb574bf053f469705b926bcc5
oai_identifier_str oai:repository.ucc.edu.co:20.500.12494/43606
network_acronym_str COOPER2
network_name_str Repositorio UCC
repository_id_str
dc.title.spa.fl_str_mv Immune characterization of a Colombian family cluster with SARS-CoV-2 infection
title Immune characterization of a Colombian family cluster with SARS-CoV-2 infection
spellingShingle Immune characterization of a Colombian family cluster with SARS-CoV-2 infection
Coronavirus infections
Inflammation
Killer cells, natural
T-lymphocytes
Antibodies
Neutralizing
Coronavirus infections
Inflammation
Killer cells, natural
T-lymphocytes
Antibodies
Neutralizing
title_short Immune characterization of a Colombian family cluster with SARS-CoV-2 infection
title_full Immune characterization of a Colombian family cluster with SARS-CoV-2 infection
title_fullStr Immune characterization of a Colombian family cluster with SARS-CoV-2 infection
title_full_unstemmed Immune characterization of a Colombian family cluster with SARS-CoV-2 infection
title_sort Immune characterization of a Colombian family cluster with SARS-CoV-2 infection
dc.creator.fl_str_mv Aguilar Jiménez, Wbeimar
Flórez Álvarez, Lizdany
Rincón, Daniel S.
Marín Palma, Damariz
Sanchez Martinez, Alexandra
Martínez Moreno, Jahnnyer
Zapata Cardona, María Isabel
Loaiza Durán, John Darío
Cardenas, Constanza
Guzman, Fanny
Velilla Hernandez, Paula Andrea
Taborda, Natalia Andrea
Zapata Builes, Wildeman
Hernández López, Juan Carlos
Diaz, Francisco Javier
Rugeles López, María Teresa
dc.contributor.author.none.fl_str_mv Aguilar Jiménez, Wbeimar
Flórez Álvarez, Lizdany
Rincón, Daniel S.
Marín Palma, Damariz
Sanchez Martinez, Alexandra
Martínez Moreno, Jahnnyer
Zapata Cardona, María Isabel
Loaiza Durán, John Darío
Cardenas, Constanza
Guzman, Fanny
Velilla Hernandez, Paula Andrea
Taborda, Natalia Andrea
Zapata Builes, Wildeman
Hernández López, Juan Carlos
Diaz, Francisco Javier
Rugeles López, María Teresa
dc.subject.spa.fl_str_mv Coronavirus infections
Inflammation
Killer cells, natural
T-lymphocytes
Antibodies
Neutralizing
topic Coronavirus infections
Inflammation
Killer cells, natural
T-lymphocytes
Antibodies
Neutralizing
Coronavirus infections
Inflammation
Killer cells, natural
T-lymphocytes
Antibodies
Neutralizing
dc.subject.other.spa.fl_str_mv Coronavirus infections
Inflammation
Killer cells, natural
T-lymphocytes
Antibodies
Neutralizing
description Introduction: Immunological markers have been described during COVID-19 and persist after recovery. These immune markers are associated with clinical features among SARSCoV- 2 infected individuals. Nevertheless, studies reporting a comprehensive analysis of the immune changes occurring during SARS-CoV-2 infection are still limited. Objective: To evaluate the production of proinflammatory cytokines, the antibody response, and the phenotype and function of NK cells and T cells in a Colombian family cluster with SARS-CoV-2 infection. Materials and methods: Proinflammatory cytokines were evaluated by RT-PCR and ELISA. The frequency, phenotype, and function of NK cells (cocultures with K562 cells) and T-cells (stimulated with spike/RdRp peptides) were assessed by flow cytometry. Anti-SARS-CoV-2 antibodies were determined using indirect immunofluorescence and plaque reduction neutralization assay. Results: During COVID-19, we observed a high proinflammatory-cytokine production and a reduced CD56bright-NK cell and cytotoxic response. Compared with healthy controls, infected individuals had a higher frequency of dysfunctional CD8+ T cells CD38+HLA-DR-. During the acute phase, CD8+ T cells stimulated with viral peptides exhibited a monofunctional response characterized by high IL-10 production. However, during recovery, we observed a bifunctional response characterized by the co-expression of CD107a and granzyme B or perforin. Conclusion: Although the proinflammatory response is a hallmark of SARS-CoV-2 infection, other phenotypic and functional alterations in NK cells and CD8+ T cells could be associated with the outcome of COVID-19. However, additional studies are required to understand these alterations and to guide future immunotherapy strategies.
publishDate 2021
dc.date.issued.none.fl_str_mv 2021-06-09
dc.date.accessioned.none.fl_str_mv 2022-02-02T21:15:12Z
dc.date.available.none.fl_str_mv 2022-02-02T21:15:12Z
dc.type.none.fl_str_mv Artículos Científicos
dc.type.coar.none.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.none.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/article
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.issn.spa.fl_str_mv 0120-4157
dc.identifier.uri.spa.fl_str_mv 10.7705/biomedica.5976
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12494/43606
dc.identifier.bibliographicCitation.spa.fl_str_mv Aguilar Jiménez, W., Florez Álvarez, L., Rincón, D.S., Marín Palma, D., Sánchez Martínez, A., Martínez, J. et al. Immune characterization of a Colombian family cluster with SARS-CoV-2 infection. Biom dica. 2021;41:86-102. https://doi.org/10.7705/biomedica.5976
identifier_str_mv 0120-4157
10.7705/biomedica.5976
Aguilar Jiménez, W., Florez Álvarez, L., Rincón, D.S., Marín Palma, D., Sánchez Martínez, A., Martínez, J. et al. Immune characterization of a Colombian family cluster with SARS-CoV-2 infection. Biom dica. 2021;41:86-102. https://doi.org/10.7705/biomedica.5976
url https://hdl.handle.net/20.500.12494/43606
dc.relation.isversionof.spa.fl_str_mv https://revistabiomedica.org/index.php/biomedica/article/view/5976
dc.relation.ispartofjournal.spa.fl_str_mv BIOMEDICA
dc.relation.references.spa.fl_str_mv 1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199-207. https://doi.org/10.1056/NEJMoa2001316
2. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418-23. https://doi.org/10.1002/jmv.25681
3. Ortiz ME, Thurman A, Pezzulo AA, Leidinger MR, Klesney-Tait JA, Karp PH, et al. Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract. EBioMedicine. 2020;60:102976. https://doi.org/10.1016/j.ebiom.2020.102976
4. Chu H, Chan JFW, Wang Y, Yuen TT, Chai Y, Hou Y, et al. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: An ex vivo study with implications for the pathogenesis of COVID-19. Clin Infect Dis. 2020;71:1400-9. https://doi.org/10.1093/cid/ciaa410
5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
6. Yuan X, Tong X, Wang Y, Wang H, Wang L, Xu X. Coagulopathy in elderly patients with coronavirus disease 2019. AGING Med. 2020;3:260-5. https://doi.org/10.1002/agm2.12133
7. Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57:1-11. https://doi.org/10.1080/10408363.2020.1770685
8. Taborda NA, Hern ndez JC, Montoya CJ, Rugeles MT. Natural killer cells and their role in the immune response during human immunodeficiency virus type-1 infection. Inmunologia. 2014;33:11-20. https://doi.org/10.1016/j.inmuno.2013.11.002
9. Alrubayyi A. NK cells in COVID-19: Protectors or opponents? Nat Rev Immunol. 2020;20:520. https://doi.org/10.1038/s41577-020-0408-0
10. Della Chiesa M, Sivori S, Carlomagno S, Moretta L, Moretta A. Activating KIRs and NKG2C in viral infections: Toward NK cell memory? Front Immunol. 2015;6:1-8. https://doi.org/10.3389/fimmu.2015.00573
11. Schlums H, Cichocki F, Tesi B, Theorell J, Beziat V, Holmes TD, et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity. 2015;42:443-56. https://doi.org/10.1016/j.immuni.2015.02.008
12. Fl rez- lvarez L, Blanquiceth Y, Contreras K, Ossa-Giraldo AC, Velilla PA, Hern ndez JC, et al. NK cell activity and CD57+/NKG2Chigh phenotype are increased in men who have sex with men at high risk for HIV. Front Immunol. 2020;11:1-14. https://doi.org/10.3389/fimmu.2020.537044
13. Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17:533-5. https://doi.org/10.1038/s41423-020-0402-2
14. Sun B, Feng Y, Mo X, Zheng P, Wang Q, Li P, et al. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Emerg Microbes Infect. 2020;9:940-8. https://doi.org/10.1080/22221751.2020.1762515
15. Wang Y, Zhang L, Sang L, Ye F, Ruan S, Zhong B, et al. Kinetics of viral load and antibody response in relation to COVID-19 severity. J Clin Invest. 2020;130:5235-44. https://doi.org/10.1172/JCI138759
16. Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis. J Intensive Care. 2020;8:1-10. https://doi.org/10.1186/s40560-020-00453-4
17. Centers for Disease Control and Prevention-CDC. Real-time RT-PCR Primers and Probes for COVID-19. Accessed on: April 2, 2020. Available from: https://www.cdc.gov/coronavirus/2019- ncov/lab/rt-pcr-panel-primer-probes.html
18. Feria MG, Taborda NA, Hern ndez JC, Rugeles MT. HIV replication is associated to inflammasomes activation, IL-1β, IL-18 and caspase-1 expression in GALT and peripheral blood. PLoS ONE. 2018;13:e0192845. https://doi.org/10.1371/journal.pone.0192845
19. Fl rez- lvarez L, Blanquiceth Y, Ram rez K, Ossa-Giraldo AC, Velilla PA, Hern ndez JC, et al. NK cell activity and CD57+/NKG2Chigh phenotype are increased in men who have sex with men at high risk for HIV. Front Immunol. 2020;11:1-14. https://doi.org/10.3389/fimmu.2020.537044
20. D az FJ, Aguilar-Jim nez W, Fl rez- lvarez L, Valencia G, Laiton-Donato K, Franco-Mu oz C, et al. Aislamiento y caracterizaci n de una cepa temprana de SARS-CoV-2 durante la epidemia de 2020 en Medell n, Colombia. Biom dica. 2020;40(Supl.2):148-58. https://doi.org/10.7705/biomedica.5834
21. Cai Y, Zhang J, Xiao T, Peng H, Sterling SM, Walsh RM, et al. Distinct conformational states of SARS-CoV-2 spike protein. Science. 2020;369:1586-92. https://doi.org/10.1126/science.abd4251
22. Gao Y, Yan L, Huang Y, Liu F, Zhao Y, Cao L, et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020;368:779-82. https://doi.org/10.1126/science.abb7498
23. Luna OF, G mez J, C rdenas C, Albericio F, Marshall SH, Guzm n F. Deprotection reagents in Fmoc solid phase peptide synthesis: Moving away from piperidine? Molecules. 2016;21:1- 12. https://doi.org/10.3390/molecules21111542
24. Perdomo-Celis F, Velilla PA, Taborda NA, Rugeles MT. An altered cytotoxic program of CD8 + T-cells in HIV-infected patients despite HAART-induced viral suppression. PLoS ONE. 2019;14:1-24. https://doi.org/10.1371/journal.pone.0210540
25. Roederer M, Nozzi JL, Nason MC. SPICE: Exploration and analysis of post-cytometric complex multivariate datasets. Cytom Part A. 2011;79:167-74. https://doi.org/10.1002/cyto.a.21015
26. Shi Y, Wang G, Cai X, Deng J, Zheng L, Zhu H, et al. An overview of COVID-19. J Zhejiang Univ Sci B. 2020;21:343-60. https://doi.org/10.1631/jzus.B2000083
27. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39:1011-9. https://doi.org/10.1007/s10096-020-03874-z
28. Garc a LF. Immune response, inflammation, and the clinical spectrum of COVID-19. Front Immunol. 2020;11:4-8. https://doi.org/10.3389/fimmu.2020.01441
29. Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC, et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy Eur J Allergy Clin Immunol. 2020;75:1564-81. https://doi.org/10.1111/all.14364
30. Ni L, Ye F, Cheng ML, Feng Y, Deng YQ, Zhao H, et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 2020;52:971- 7.e3. https://doi.org/10.1016/j.immuni.2020.04.023
31. Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci USA. 2020;117:9490-6. https://doi.org/10.1073/pnas.2004168117
32. Wang X, Guo X, Xin Q, Pan Y, Hu Y, Li J, et al. Neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in coronavirus disease 2019 in patients and convalescent patients. Clin Infect Dis. 2020;71:2688-94. https://doi.org/10.1093/cid/ciaa721
33. Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26:1200-4. https://doi.org/10.1038/s41591-020-0965-6
34. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71:762-8. https://doi:10.1093/cid/ciaa248
35. Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9:1123-30. https://doi.org/10.1080/22221751.2020.1770129
36. Le Garff-Tavernier M, B ziat V, Decocq J, Siguret V, Gandjbakhch F, Pautas E, et al. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell. 2010;9:527-35. https://doi.org/10.1111/j.1474-9726.2010.00584.x
37. Kang CK, Han GC, Kim M, Kim G, Shin HM, Song KH, et al. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity. Int J Infect Dis. 2020;97:313- 21. https://doi.org/10.1016/j.ijid.2020.05.106
38. Payen D, Cravat M, Maadadi H, Didelot C, Prosic L, Dupuis C, et al. A longitudinal study of immune cells in severe COVID-19 patients. Front Immunol. 2020:11:580250. https://doi.org/10.3389/fimmu.2020.580250
39. Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020:130:4694-703. https://doi:10.1172/jci138554
40. Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020;17:541-3. https://doi.org/10.1038/s41423-020-0401-3
41. De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020;11:1-17. https://doi.org/10.1038/s41467-020-17292-4
dc.rights.license.none.fl_str_mv Atribución
dc.rights.accessrights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv Atribución
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 17
dc.coverage.temporal.spa.fl_str_mv 41(Supl. 2)
dc.publisher.spa.fl_str_mv Grupo Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellin, Colombia
Instituto Nacional de Salud
dc.publisher.program.spa.fl_str_mv Medicina
dc.publisher.place.spa.fl_str_mv Medellín
institution Universidad Cooperativa de Colombia
bitstream.url.fl_str_mv https://repository.ucc.edu.co/bitstreams/fe4cf4a3-e951-4453-8dfb-d2b76f46f07d/download
https://repository.ucc.edu.co/bitstreams/8620e2d8-9ff6-4785-aa02-c8cc5cbd753b/download
https://repository.ucc.edu.co/bitstreams/1f371001-a842-4b17-887b-7a3ec09a2072/download
https://repository.ucc.edu.co/bitstreams/db64a3cf-cc52-47ee-b501-a96132ef5666/download
bitstream.checksum.fl_str_mv 7a3a02af2a8082abcdac8a732c19fd76
3bce4f7ab09dfc588f126e1e36e98a45
6162538660b5dd1ae13ba4ccf3b65b95
71dc4a5d223703bd88dc23403dd75eb7
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad Cooperativa de Colombia
repository.mail.fl_str_mv bdigital@metabiblioteca.com
_version_ 1811564877167198208
spelling Aguilar Jiménez, WbeimarFlórez Álvarez, LizdanyRincón, Daniel S.Marín Palma, DamarizSanchez Martinez, AlexandraMartínez Moreno, JahnnyerZapata Cardona, María IsabelLoaiza Durán, John DaríoCardenas, ConstanzaGuzman, FannyVelilla Hernandez, Paula AndreaTaborda, Natalia AndreaZapata Builes, WildemanHernández López, Juan CarlosDiaz, Francisco Javier Rugeles López, María Teresa41(Supl. 2)2022-02-02T21:15:12Z2022-02-02T21:15:12Z2021-06-090120-415710.7705/biomedica.5976https://hdl.handle.net/20.500.12494/43606Aguilar Jiménez, W., Florez Álvarez, L., Rincón, D.S., Marín Palma, D., Sánchez Martínez, A., Martínez, J. et al. Immune characterization of a Colombian family cluster with SARS-CoV-2 infection. Biom dica. 2021;41:86-102. https://doi.org/10.7705/biomedica.5976Introduction: Immunological markers have been described during COVID-19 and persist after recovery. These immune markers are associated with clinical features among SARSCoV- 2 infected individuals. Nevertheless, studies reporting a comprehensive analysis of the immune changes occurring during SARS-CoV-2 infection are still limited. Objective: To evaluate the production of proinflammatory cytokines, the antibody response, and the phenotype and function of NK cells and T cells in a Colombian family cluster with SARS-CoV-2 infection. Materials and methods: Proinflammatory cytokines were evaluated by RT-PCR and ELISA. The frequency, phenotype, and function of NK cells (cocultures with K562 cells) and T-cells (stimulated with spike/RdRp peptides) were assessed by flow cytometry. Anti-SARS-CoV-2 antibodies were determined using indirect immunofluorescence and plaque reduction neutralization assay. Results: During COVID-19, we observed a high proinflammatory-cytokine production and a reduced CD56bright-NK cell and cytotoxic response. Compared with healthy controls, infected individuals had a higher frequency of dysfunctional CD8+ T cells CD38+HLA-DR-. During the acute phase, CD8+ T cells stimulated with viral peptides exhibited a monofunctional response characterized by high IL-10 production. However, during recovery, we observed a bifunctional response characterized by the co-expression of CD107a and granzyme B or perforin. Conclusion: Although the proinflammatory response is a hallmark of SARS-CoV-2 infection, other phenotypic and functional alterations in NK cells and CD8+ T cells could be associated with the outcome of COVID-19. However, additional studies are required to understand these alterations and to guide future immunotherapy strategies.Introduction: Immunological markers have been described during COVID-19 and persist after recovery. These immune markers are associated with clinical features among SARSCoV- 2 infected individuals. Nevertheless, studies reporting a comprehensive analysis of the immune changes occurring during SARS-CoV-2 infection are still limited. Objective: To evaluate the production of proinflammatory cytokines, the antibody response, and the phenotype and function of NK cells and T cells in a Colombian family cluster with SARS-CoV-2 infection. Materials and methods: Proinflammatory cytokines were evaluated by RT-PCR and ELISA. The frequency, phenotype, and function of NK cells (cocultures with K562 cells) and T-cells (stimulated with spike/RdRp peptides) were assessed by flow cytometry. Anti-SARS-CoV-2 antibodies were determined using indirect immunofluorescence and plaque reduction neutralization assay. Results: During COVID-19, we observed a high proinflammatory-cytokine production and a reduced CD56bright-NK cell and cytotoxic response. Compared with healthy controls, infected individuals had a higher frequency of dysfunctional CD8+ T cells CD38+HLA-DR-. During the acute phase, CD8+ T cells stimulated with viral peptides exhibited a monofunctional response characterized by high IL-10 production. However, during recovery, we observed a bifunctional response characterized by the co-expression of CD107a and granzyme B or perforin. Conclusion: Although the proinflammatory response is a hallmark of SARS-CoV-2 infection, other phenotypic and functional alterations in NK cells and CD8+ T cells could be associated with the outcome of COVID-19. However, additional studies are required to understand these alterations and to guide future immunotherapy strategies.https://scienti.minciencias.gov.co/cvlac/EnProdArticulo/query.do?cod_producto=73&cod_rh=0000157775https://orcid.org/0000-0002-7351-8738COL0112548wildeman.zapatab@campusucc.edu.cohttps://scholar.google.com.co/citations?hl=en&user=VLZxl1UAAAAJ17Grupo Infettare, Facultad de Medicina, Universidad Cooperativa de Colombia, Medellin, ColombiaInstituto Nacional de SaludMedicinaMedellínhttps://revistabiomedica.org/index.php/biomedica/article/view/5976BIOMEDICA1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199-207. https://doi.org/10.1056/NEJMoa20013162. Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418-23. https://doi.org/10.1002/jmv.256813. Ortiz ME, Thurman A, Pezzulo AA, Leidinger MR, Klesney-Tait JA, Karp PH, et al. Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract. EBioMedicine. 2020;60:102976. https://doi.org/10.1016/j.ebiom.2020.1029764. Chu H, Chan JFW, Wang Y, Yuen TT, Chai Y, Hou Y, et al. Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: An ex vivo study with implications for the pathogenesis of COVID-19. Clin Infect Dis. 2020;71:1400-9. https://doi.org/10.1093/cid/ciaa4105. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506. https://doi.org/10.1016/S0140-6736(20)30183-56. Yuan X, Tong X, Wang Y, Wang H, Wang L, Xu X. Coagulopathy in elderly patients with coronavirus disease 2019. AGING Med. 2020;3:260-5. https://doi.org/10.1002/agm2.121337. Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci. 2020;57:1-11. https://doi.org/10.1080/10408363.2020.17706858. Taborda NA, Hern ndez JC, Montoya CJ, Rugeles MT. Natural killer cells and their role in the immune response during human immunodeficiency virus type-1 infection. Inmunologia. 2014;33:11-20. https://doi.org/10.1016/j.inmuno.2013.11.0029. Alrubayyi A. NK cells in COVID-19: Protectors or opponents? Nat Rev Immunol. 2020;20:520. https://doi.org/10.1038/s41577-020-0408-010. Della Chiesa M, Sivori S, Carlomagno S, Moretta L, Moretta A. Activating KIRs and NKG2C in viral infections: Toward NK cell memory? Front Immunol. 2015;6:1-8. https://doi.org/10.3389/fimmu.2015.0057311. Schlums H, Cichocki F, Tesi B, Theorell J, Beziat V, Holmes TD, et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity. 2015;42:443-56. https://doi.org/10.1016/j.immuni.2015.02.00812. Fl rez- lvarez L, Blanquiceth Y, Contreras K, Ossa-Giraldo AC, Velilla PA, Hern ndez JC, et al. NK cell activity and CD57+/NKG2Chigh phenotype are increased in men who have sex with men at high risk for HIV. Front Immunol. 2020;11:1-14. https://doi.org/10.3389/fimmu.2020.53704413. Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020;17:533-5. https://doi.org/10.1038/s41423-020-0402-214. Sun B, Feng Y, Mo X, Zheng P, Wang Q, Li P, et al. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Emerg Microbes Infect. 2020;9:940-8. https://doi.org/10.1080/22221751.2020.176251515. Wang Y, Zhang L, Sang L, Ye F, Ruan S, Zhong B, et al. Kinetics of viral load and antibody response in relation to COVID-19 severity. J Clin Invest. 2020;130:5235-44. https://doi.org/10.1172/JCI13875916. Huang I, Pranata R. Lymphopenia in severe coronavirus disease-2019 (COVID-19): Systematic review and meta-analysis. J Intensive Care. 2020;8:1-10. https://doi.org/10.1186/s40560-020-00453-417. Centers for Disease Control and Prevention-CDC. Real-time RT-PCR Primers and Probes for COVID-19. Accessed on: April 2, 2020. Available from: https://www.cdc.gov/coronavirus/2019- ncov/lab/rt-pcr-panel-primer-probes.html18. Feria MG, Taborda NA, Hern ndez JC, Rugeles MT. HIV replication is associated to inflammasomes activation, IL-1β, IL-18 and caspase-1 expression in GALT and peripheral blood. PLoS ONE. 2018;13:e0192845. https://doi.org/10.1371/journal.pone.019284519. Fl rez- lvarez L, Blanquiceth Y, Ram rez K, Ossa-Giraldo AC, Velilla PA, Hern ndez JC, et al. NK cell activity and CD57+/NKG2Chigh phenotype are increased in men who have sex with men at high risk for HIV. Front Immunol. 2020;11:1-14. https://doi.org/10.3389/fimmu.2020.53704420. D az FJ, Aguilar-Jim nez W, Fl rez- lvarez L, Valencia G, Laiton-Donato K, Franco-Mu oz C, et al. Aislamiento y caracterizaci n de una cepa temprana de SARS-CoV-2 durante la epidemia de 2020 en Medell n, Colombia. Biom dica. 2020;40(Supl.2):148-58. https://doi.org/10.7705/biomedica.583421. Cai Y, Zhang J, Xiao T, Peng H, Sterling SM, Walsh RM, et al. Distinct conformational states of SARS-CoV-2 spike protein. Science. 2020;369:1586-92. https://doi.org/10.1126/science.abd425122. Gao Y, Yan L, Huang Y, Liu F, Zhao Y, Cao L, et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020;368:779-82. https://doi.org/10.1126/science.abb749823. Luna OF, G mez J, C rdenas C, Albericio F, Marshall SH, Guzm n F. Deprotection reagents in Fmoc solid phase peptide synthesis: Moving away from piperidine? Molecules. 2016;21:1- 12. https://doi.org/10.3390/molecules2111154224. Perdomo-Celis F, Velilla PA, Taborda NA, Rugeles MT. An altered cytotoxic program of CD8 + T-cells in HIV-infected patients despite HAART-induced viral suppression. PLoS ONE. 2019;14:1-24. https://doi.org/10.1371/journal.pone.021054025. Roederer M, Nozzi JL, Nason MC. SPICE: Exploration and analysis of post-cytometric complex multivariate datasets. Cytom Part A. 2011;79:167-74. https://doi.org/10.1002/cyto.a.2101526. Shi Y, Wang G, Cai X, Deng J, Zheng L, Zhu H, et al. An overview of COVID-19. J Zhejiang Univ Sci B. 2020;21:343-60. https://doi.org/10.1631/jzus.B200008327. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39:1011-9. https://doi.org/10.1007/s10096-020-03874-z28. Garc a LF. Immune response, inflammation, and the clinical spectrum of COVID-19. Front Immunol. 2020;11:4-8. https://doi.org/10.3389/fimmu.2020.0144129. Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC, et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy Eur J Allergy Clin Immunol. 2020;75:1564-81. https://doi.org/10.1111/all.1436430. Ni L, Ye F, Cheng ML, Feng Y, Deng YQ, Zhao H, et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 2020;52:971- 7.e3. https://doi.org/10.1016/j.immuni.2020.04.02331. Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci USA. 2020;117:9490-6. https://doi.org/10.1073/pnas.200416811732. Wang X, Guo X, Xin Q, Pan Y, Hu Y, Li J, et al. Neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in coronavirus disease 2019 in patients and convalescent patients. Clin Infect Dis. 2020;71:2688-94. https://doi.org/10.1093/cid/ciaa72133. Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26:1200-4. https://doi.org/10.1038/s41591-020-0965-634. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71:762-8. https://doi:10.1093/cid/ciaa24835. Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9:1123-30. https://doi.org/10.1080/22221751.2020.177012936. Le Garff-Tavernier M, B ziat V, Decocq J, Siguret V, Gandjbakhch F, Pautas E, et al. Human NK cells display major phenotypic and functional changes over the life span. Aging Cell. 2010;9:527-35. https://doi.org/10.1111/j.1474-9726.2010.00584.x37. Kang CK, Han GC, Kim M, Kim G, Shin HM, Song KH, et al. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity. Int J Infect Dis. 2020;97:313- 21. https://doi.org/10.1016/j.ijid.2020.05.10638. Payen D, Cravat M, Maadadi H, Didelot C, Prosic L, Dupuis C, et al. A longitudinal study of immune cells in severe COVID-19 patients. Front Immunol. 2020:11:580250. https://doi.org/10.3389/fimmu.2020.58025039. Mazzoni A, Salvati L, Maggi L, Capone M, Vanni A, Spinicci M, et al. Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020:130:4694-703. https://doi:10.1172/jci13855440. Zheng HY, Zhang M, Yang CX, Zhang N, Wang XC, Yang XP, et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020;17:541-3. https://doi.org/10.1038/s41423-020-0401-341. De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L, et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020;11:1-17. https://doi.org/10.1038/s41467-020-17292-4Coronavirus infectionsInflammationKiller cells, naturalT-lymphocytesAntibodiesNeutralizingCoronavirus infectionsInflammationKiller cells, naturalT-lymphocytesAntibodiesNeutralizingImmune characterization of a Colombian family cluster with SARS-CoV-2 infectionArtículos Científicoshttp://purl.org/coar/resource_type/c_2df8fbb1http://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAtribucióninfo:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2PublicationORIGINALImmune characterization of a Colombian Family UCC_UdeA 2021.pdfImmune characterization of a Colombian Family UCC_UdeA 2021.pdfArtículoapplication/pdf1314953https://repository.ucc.edu.co/bitstreams/fe4cf4a3-e951-4453-8dfb-d2b76f46f07d/download7a3a02af2a8082abcdac8a732c19fd76MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-84334https://repository.ucc.edu.co/bitstreams/8620e2d8-9ff6-4785-aa02-c8cc5cbd753b/download3bce4f7ab09dfc588f126e1e36e98a45MD52THUMBNAILImmune characterization of a Colombian Family UCC_UdeA 2021.pdf.jpgImmune characterization of a Colombian Family UCC_UdeA 2021.pdf.jpgGenerated Thumbnailimage/jpeg6053https://repository.ucc.edu.co/bitstreams/1f371001-a842-4b17-887b-7a3ec09a2072/download6162538660b5dd1ae13ba4ccf3b65b95MD53TEXTImmune characterization of a Colombian Family UCC_UdeA 2021.pdf.txtImmune characterization of a Colombian Family UCC_UdeA 2021.pdf.txtExtracted texttext/plain56546https://repository.ucc.edu.co/bitstreams/db64a3cf-cc52-47ee-b501-a96132ef5666/download71dc4a5d223703bd88dc23403dd75eb7MD5420.500.12494/43606oai:repository.ucc.edu.co:20.500.12494/436062024-08-10 22:48:20.722restrictedhttps://repository.ucc.edu.coRepositorio Institucional Universidad Cooperativa de Colombiabdigital@metabiblioteca.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